Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model

BACKGROUND: Colitis-associated cancer (CAC) accounts for 2%-3% of colorectal cancer (CRC) cases preceded by inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. Intestinal microbiota has been reported to play a central role in the pathogenesis of IBD and CAC. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Silveira, Denise Sayuri Calheiros, Veronez, Luciana Chain, Lopes-Júnior, Luís Carlos, Anatriello, Elen, Brunaldi, Mariângela Ottoboni, Pereira-da-Silva, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684459/
https://www.ncbi.nlm.nih.gov/pubmed/33268961
http://dx.doi.org/10.3748/wjg.v26.i43.6782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684459/
https://www.ncbi.nlm.nih.gov/pubmed/33268961
http://dx.doi.org/10.3748/wjg.v26.i43.6782

Ejemplares similares